Antisense Technology
Antitumor Effect of Targeting C-raf Kinase Studied
Published in Cancer Weekly, July 15th, 1996
Antisense oligonucleotides act by specifically hybridizing with complementary RNA sequences. They inhibit protein expression through a number of mechanisms including degradation of the targeted RNA through RNase H-mediated cleavage. Because of these properties, antisense oligonucleotides might have therapeutic value as antineoplastic agents when targeted to appropriate molecular targets and possibly prevent the initiation or progression of specific cancers.
Brett P. Monia et al....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1996-07-15)
More Articles from Cancer Weekly
- Antisense Technology
TGF-(beta) Antisense Gene Therapy Shows Promise Against Glioblastoma Multiform - Adoptive Immunotherapy
Rapid Activation and Expansion of Antiviral and Antitumor CTLs - Brain Cancer
U.S. Patent Received Covering Method To Treat Glioma - Breast/Ovarian Cancers (Genetics)
Many People Prefer Not To Know If They Have Gene Linked to Cancers - Cancer Gene Therapy
Cancer Targeted in Gene Therapy Clinical Trial - Carcinogenesis (HCV)
IGF-II Activation May Be Involved in HCV Related HCC - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
